GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Nath Bio-Genes (India) Ltd (BOM:537291) » Definitions » Capex-to-Operating-Cash-Flow

Nath Bio-Genes (India) (BOM:537291) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Nath Bio-Genes (India) Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Nath Bio-Genes (India)'s Capital Expenditure for the three months ended in Mar. 2024 was ₹0.00 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was ₹0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Nath Bio-Genes (India) Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nath Bio-Genes (India) Capex-to-Operating-Cash-Flow Chart

Nath Bio-Genes (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 10.42 0.07 0.07 0.12

Nath Bio-Genes (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow

For the Agricultural Inputs subindustry, Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow falls into.



Nath Bio-Genes (India) Capex-to-Operating-Cash-Flow Calculation

Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-83.929) / 702.688
=0.12

Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nath Bio-Genes (India)  (BOM:537291) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Nath Bio-Genes (India) Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nath Bio-Genes (India)'s Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Nath Bio-Genes (India) (BOM:537291) Business Description

Traded in Other Exchanges
Address
Nath House, Nath Road, Chhatrapati Sambhajinagar, MH, IND, 431005
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.

Nath Bio-Genes (India) (BOM:537291) Headlines

No Headlines